companydata.dkcompanydata.dk

Fenucure Medical ApS: Financial statements 2025

CVR: 28486871

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Fenucure Medical ApS (CVR 28486871) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -1,214,608 and a net result of DKK -3,201,378 compared with DKK -1,529,007 the year before. Equity in the 2025 report amounted to DKK 593,861. The solvency ratio was 30.2%. The company had 2 employees in the financial year.

Gross Profit
DKK -1,214,608
Profit/Loss
DKK -3,201,378
Equity
DKK 593,861
Total Assets
DKK 1,963,920
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--1.2M-3.2M594K2
2024--873K-1.5M795K2
2023--912K-2.1M-1.7M2
2022--1.6M-3.5M-3.6M2
2021--1.7M-4.5M-2.5M2

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Fenucure Medical ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Fenucure Medical ApS: The 2024 annual report is outJun 4, 2025

Fenucure Medical ApS has published its annual report for 2024. Gross profit came to DKK -873,428, and the net result was DKK -1,529,007.

Mogens Viktor Madsen joins the board of Fenucure Medical ApSMay 28, 2025

As of May 28, 2025, Mogens Viktor Madsen has joined the board of directors of Fenucure Medical ApS.

Preben Andersen leaves the board of Fenucure Medical ApSMay 28, 2025

As of May 28, 2025, Preben Andersen has left the board of directors of Fenucure Medical ApS.

About Fenucure Medical ApS

Fenucure Medical ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2005. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named V-BIOTEK ApS and VIND INVEST ApS. The management consists of Christian Hother Sørensen. The board consists of Nicolai Fink Gundersen (chair), Alex Gundersen, Mogens Viktor Madsen and Niels Christian Beck Vase. The company is owned by V-BIOTEK HOLDING ApS, Redwood Foundation ApS and Alex Gundersen Assens ApS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -1,214,608 and a net result of DKK -3,201,378 compared with DKK -1,529,007 the year before. Equity in the 2025 report amounted to DKK 593,861.

Source: annual report 2025, Danish Business Authority